Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1135 of 3330
Next
>>
>
28351 to 28375 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	0.0000853	uM	7870.016	1.0055	1.0052	2.1045
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	0.000427	uM	7870.016	0.9718	0.9730	2.1045
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	0.00213	uM	7870.016	1.0061	1.0058	2.1045
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	0.0107	uM	7870.016	1.0480	1.0451	2.1045
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	0.0533	uM	7870.016	1.0516	1.0484	2.1045
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	0.267	uM	7870.016	0.8186	0.8185	2.1045
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	1.33	uM	7870.016	0.1757	-0.1247	2.1045
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	6.67	uM	7870.016	0.1652	-0.1500	2.1045
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	33.3	uM	7870.016	0.0438	-0.5476	2.1045
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	0.0000853	uM	9551.132	0.9952	0.9966	2.8612
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	0.000427	uM	9551.132	1.0815	1.0555	2.8612
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	0.00213	uM	9551.132	0.9206	0.9430	2.8612
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	0.0107	uM	9551.132	1.0923	1.0627	2.8612
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	0.0533	uM	9551.132	0.9692	0.9783	2.8612
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	0.267	uM	9551.132	1.0454	1.0313	2.8612
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	1.33	uM	9551.132	0.7367	0.7975	2.8612
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	6.67	uM	9551.132	1.1019	1.0690	2.8612
MCF 10A	NM	Basal B	Gefitinib	EGFR	ErbB	33.3	uM	9551.132	0.6830	0.7505	2.8612
MCF 10F	NM	-	Gefitinib	EGFR	ErbB	0.0000853	uM	7488.016	1.0058	1.0095	1.2238
MCF 10F	NM	-	Gefitinib	EGFR	ErbB	0.000427	uM	7488.016	0.9862	0.9774	1.2238
MCF 10F	NM	-	Gefitinib	EGFR	ErbB	0.00213	uM	7488.016	0.9844	0.9745	1.2238
MCF 10F	NM	-	Gefitinib	EGFR	ErbB	0.0107	uM	7488.016	0.9740	0.9574	1.2238
MCF 10F	NM	-	Gefitinib	EGFR	ErbB	0.0533	uM	7488.016	0.9653	0.9431	1.2238
MCF 10F	NM	-	Gefitinib	EGFR	ErbB	0.267	uM	7488.016	0.7083	0.5089	1.2238
MCF 10F	NM	-	Gefitinib	EGFR	ErbB	1.33	uM	7488.016	0.2948	-0.2628	1.2238

|<
<<
Previous
Page 1135 of 3330
Next
>>
>
28351 to 28375 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)